Clinical trial
Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic…
NCT00148980 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00148980 |
|---|---|
| Title | Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation |
| Official title | Creation of Bone Marrow Microenvironment for Treatment of MDS in Conjunction With Allogeneic Stem Cell Transplantation |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes, Myelofibrosis |
| Intervention type | Device |
| Interventions | DBM for creation of bone marrow microenvironment |
| Enrollment | 24 |
| Start date | Apr 1, 2003 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 28, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: